Published in Haematologica on February 24, 2015
Impact of Viral Infections on Hematopoiesis: From Beneficial to Detrimental Effects on Bone Marrow Output. Front Immunol (2016) 0.76
Identification of IFN-γ-producing T cells as the main mediators of the side effects associated to mouse interleukin-15 sustained exposure. Oncotarget (2016) 0.75
Complementary Effects of Interleukin-15 and Alpha Interferon Induce Immunity in Hepatitis B Virus Transgenic Mice. J Virol (2016) 0.75
CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature (2006) 7.17
IFNalpha activates dormant haematopoietic stem cells in vivo. Nature (2009) 7.17
Interferons alpha and beta as immune regulators--a new look. Immunity (2001) 4.75
Regulation of type I interferon responses. Nat Rev Immunol (2014) 3.60
Awakening dormant haematopoietic stem cells. Nat Rev Immunol (2010) 2.88
Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy. Hepatology (2013) 2.66
GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation. Nat Rev Immunol (2009) 2.43
Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response. Nat Rev Immunol (2011) 2.38
Virus-induced transient bone marrow aplasia: major role of interferon-alpha/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus. J Exp Med (1997) 1.93
Early B cell factor promotes B lymphopoiesis with reduced interleukin 7 responsiveness in the absence of E2A. J Exp Med (2004) 1.83
The earliest step in B lineage differentiation from common lymphoid progenitors is critically dependent upon interleukin 7. J Exp Med (2002) 1.61
Interleukin-7 is necessary to maintain the B cell potential in common lymphoid progenitors. J Exp Med (2005) 1.59
Regulation of effector and memory T-cell functions by type I interferon. Immunology (2011) 1.58
GATA-3 is required for early T lineage progenitor development. J Exp Med (2009) 1.56
Deltex1 redirects lymphoid progenitors to the B cell lineage by antagonizing Notch1. Immunity (2002) 1.55
Mechanisms and management of toxicities associated with high-dose interferon alfa-2b therapy. J Clin Oncol (2002) 1.28
Transcription factor EBF1 is essential for the maintenance of B cell identity and prevention of alternative fates in committed cells. Nat Immunol (2013) 1.21
Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons. J Exp Med (2014) 1.18
Interferon-alpha causes neuronal dysfunction in encephalitis. J Neurosci (2009) 1.18
IFN-α in the treatment of melanoma. J Immunol (2012) 1.12
Effect of recombinant interferons alpha and gamma on human bone marrow-derived megakaryocytic progenitor cells. Blood (1987) 1.06
Development of a liver-specific Tet-on inducible system for AAV vectors and its application in the treatment of liver cancer. Mol Ther (2011) 1.03
Neutrophil-mediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus. J Immunol (2013) 1.01
NOTCH1 promotes T cell leukemia-initiating activity by RUNX-mediated regulation of PKC-θ and reactive oxygen species. Nat Med (2012) 1.00
IFNα Inducible Models of Murine SLE. Front Immunol (2013) 0.97
Cytotoxic T cells induce proliferation of chronic myeloid leukemia stem cells by secreting interferon-γ. J Exp Med (2013) 0.96
Human T cell leukemia virus-I-associated T-suppressor cell inhibition of erythropoiesis in a patient with pure red cell aplasia and chronic T gamma-lymphoproliferative disease. J Clin Invest (1988) 0.96
Divergent effects of supraphysiologic Notch signals on leukemia stem cells and hematopoietic stem cells. Blood (2012) 0.95
IFN-α as a vaccine adjuvant: recent insights into the mechanisms and perspectives for its clinical use. Expert Rev Vaccines (2011) 0.93
T lineage progenitors: the earliest steps en route to T lymphocytes. Curr Opin Immunol (2006) 0.93
Suppressive effect of interferon on erythroid cell proliferation. Exp Hematol (1979) 0.87
Inhibitory effects of interferon on mouse megakaryocytic progenitor cells in culture. Exp Hematol (1980) 0.86
Induction of T-cell development by Delta-like 4-expressing fibroblasts. Int Immunol (2013) 0.83
Biological therapy and the immune system in patients with chronic myeloid leukemia. Int J Hematol (2012) 0.82
Suppression of normal human erythropoiesis by human recombinant DNA-produced alpha-2-interferon in vitro. Exp Hematol (1986) 0.78
Human leukocyte interferon preparation-mediated block of granulopoietic differentiation in vitro. Exp Hematol (1981) 0.77